Latest News

November 01, 2010
Rapamycin, an FDA-approved drug prescribed to prevent the rejection of transplanted organs, has been shown for the first time to decrease excessive alcohol consumption, binge drinking, and alcohol-seeking behavior in rodents.
November 01, 2010
Anti-inflammatory drugs currently used to treat diseases such as rheumatoid arthritis may also help prevent cognitive decline after surgery, according to a new study led by researchers at UCSF and colleagues at Imperial College London.
October 29, 2010
The Lancet launched a special series on malaria elimination Oct. 29, led by the Global Health Group (GHG), a part of UCSF Global Health Sciences. The series included work by 36 authors worldwide, with guidance and support provided by a GHG-convened global advisory group of malaria experts, known as the Malaria Elimination Group.
October 25, 2010
A UCSF cancer education project has received the 2010 Faith Fancher Award from the California Breast Cancer Research Program, as well as a $600,000 grant recognizing the best proposal focused on underserved populations.
October 18, 2010
An invited commentary in the Oct. 11 Archives of Internal Medicine, titled "A Prescription for Improved Chronic Disease Management,” highlights the current and potential role of pharmacists in preventing and treating chronic diseases.
October 08, 2010
A woman’s race/ethnicity and socioeconomic status impact whether health care providers recommend one of the most highly effective forms of contraception, a UCSF study confirms. The results also indicate that the interaction of both factors plays a role in clinicians’ decisions.
October 06, 2010
Patients who cannot discuss their diabetes with a doctor in their own language may have poorer health outcomes, even when interpreter services are available, according to a new study by researchers at UCSF and the Kaiser Permanente Division of Research.
October 05, 2010
A diet supplemented with powdered dried plum restored bone lost by mice during the course of normal aging, in a study led by Bernard P. Halloran, PhD, at the San Francisco VA Medical Center.
September 29, 2010
A particularly aggressive childhood cancer can be fought successfully with far less chemotherapy than previously believed, avoiding harmful side effects caused by cancer drugs.
September 28, 2010
Surgical patients with known heart disease risks who are given beta blockers around the time of surgery have a significantly reduced risk of post-operative death compared with patients not given beta blockers, according to a study by researchers at the San Francisco VA Medical Center.

Pages